The effect of exenatide on body weight, energy expenditure and hunger in obese women without diabetes mellitus

Trial Profile

The effect of exenatide on body weight, energy expenditure and hunger in obese women without diabetes mellitus

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Aug 2012

At a glance

  • Drugs Exenatide (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Feb 2012 Actual end date (September 2010) added as reported by ClinicalTrials.gov.
    • 24 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 31 Oct 2011 Results published in the Diabetes Care.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top